Clinical Trials Sponsored by Tianjin SinoBiotech Ltd.

Total 490 results

Tianjin SinoBiotech Ltd.

Completed

Study of Recombinant Human Serum Albumin/Interferon alpha2b Fusion Protein in Hepatitis B Patient

Hepatitis B Virus

China
Tianjin SinoBiotech Ltd.

Completed

Study of Recombinant Human Serum Albumin/Granulocyte Colony-Stimulating Factor Fusion Protein

Chemotherapy-induced Neutropenia

China
Tianjin SinoBiotech Ltd.

Completed

Study on Single Administration and Dose Increment of Recombinant Human Serum Albumin/Erythrocyte Fusion Protein for Injection

Healthy Subjects

China
Tianjin SinoBiotech Ltd.

Completed

Recombinant Human Serum Albumin/Granulocyte Colony Stimulating Factor Fusion Protein for Breast Cancer Patients

Chemotherapy-induced Neutropenia

China
Tianjin SinoBiotech Ltd.

Completed

Fusion Protein rHSA/GCSFclinical Study on Breast Cancer Patients

Cancer, Breast | Chemotherapy-induced Neutropenia

China
Tianjin SinoBiotech Ltd.

Completed

Study of Recombinant Human Serum Albumin/Interferon alpha2b Fusion Protein in Chinese Healthy Volunteers

Healthy

China
Tianjin SinoBiotech Ltd.
Peking University Cancer Hospital & Institute

Completed

Safety and Efficacy Studies of rHSA/GCSF Fusion Protein For Injection to Treat Neutropenia

Cancer | Tumor | Underdose (Unintentional)

China
Ruijin Hospital
Chongqing Kingbiotech Co.,Ltd

Not yet recruiting

In Vitro Organoid Drug Sensitivity-Guided Treatment for Advanced Pancreatic Neuroendocrine Tumor

Advanced Pancreatic Neuroendocrine Tumor

China
Tianjin Weikai Bioeng., Ltd.
Tianjin Nankai Hospital

Unknown

Safety and Efficacy of Mesenchymal Stem Cell Transplantation for Acute-on-Chronic Liver Failure

Liver Failure, Acute on Chronic

China
Tianjin ConjuStar Biologics Co., Ltd.

Recruiting

Study SC-101 in Subjects With Advanced Malignancies

Advanced Solid Tumor

China
Tasly Tianjin Biopharmaceutical Co., Ltd.

Unknown

Safety and Efficacy of Therapeutic Hepatitis B Adenovirus Injection (T101) Combined With Nucleoside (Acid) Analogues in Chronic Hepatitis B Patients

Hepatitis B Virus (HBV)

China
Servier (Tianjin) Pharmaceutical Co. LTD.

Completed

Study of Combination Therapy of Gliclazide MR and Basal Insulin Versus Insulin Monotherapy to Treat Type 2 Diabetes (CODMS)

Type 2 Diabetes

China
Tianjin Chasesun Pharmaceutical Co., LTD

Enrolling by invitation

A Study of IMMH-010 in Patients With Advanced Malignant Solid Tumors

Malignant Neoplasms

China
Tasly Tianjin Biopharmaceutical Co., Ltd.

Completed

Safety and Efficacy of Therapeutic Hepatitis B Adenovirus Injection (T101) in Chronic Hepatitis B Patients

Hepatitis B Virus (HBV)

China
Tasly Tianjin Biopharmaceutical Co., Ltd.

Unknown

Safety, Tolerability and Pharmacokinetics Characteristics of Recombinant Oncolytic Vaccinia Virus Injection T601 as a Single Drug or in Combination With Oral Flucytosine (5-FC), in Patients With Advanced Malignant Solid Tumors

Advanced Malignant Solid Tumors

China
Tianjin Hemay Oncology Pharmaceutical Co., Ltd

Recruiting

A Phase Ⅲ Study of the Efficacy and Safety of Hemay022+Aromatase Inhibitor(AI) in Participants With ER+/HER2+ Advanced or Metastatic Breast Cancer (Fillful-03)

Breast Cancer

China
Tianjin Hemay Oncology Pharmaceutical Co., Ltd

Unknown

A Food-Effect Study of Hemay022 in Healthy Participants

Food-drug Interaction

China
Tianjin Happy Life Technology Co., Ltd.

Unknown

Outcomes for Patients With Gastro-Esophageal Reflux Disease

Gastro-esophageal Reflux Disease

China
Tianjin Mycure Medical Technology Co., Ltd

Unknown

CD19 CAR-T Cells for Patients With Relapse and Refractory CD19+ B-ALL.

B-cell Acute Lymphoblastic Leukemia

China
Tianjin XinChen-Techfields Pharma Co., LTD.

Completed

Study of X0002 Following Escalating Single and Multiple Doses Administered as Topical Application in Healthy Volunteers

Osteoarthritis

China
Tianjin Hemay Bio-Tech Co., Ltd

Completed

Safety and Pharmacokinetics of Hemay005 In Healthy Male Subjects

Psoriasis

China
Koning (Tianjin) Medical Equipment Co., Ltd

Completed

Koning Breast CT for Breast Imaging in China

Breast Cancer

China
Tianjin Hemay Bio-Tech Co., Ltd

Unknown

Multiple Ascending Dose Study to Assess Safety and Pharmacokinetics of Hemay005 In Healthy Subjects

Psoriasis

China
Tianjin Hemay Bio-Tech Co., Ltd

Unknown

A Food Effect Study to Assess Pharmacokinetics of Hemay005 in Healthy Volunteers

Psoriasis
Tianjin Hemay Oncology Pharmaceutical Co., Ltd

Recruiting

Phase I Study of Hemay102 in Patients With Advanced Solid Tumors

Patients With Advanced Stage Solid Tumors

China
Tianjin XinChen-Techfields Pharma Co., LTD.

Completed

Evaluate Efficacy and Safety of X0002 in Treatment of Knee Osteoarthritis

KNEE OSTEOARTHRITIS

China
Tianjin Ever Union Biotechnology Co., Ltd.

Unknown

Safety and Efficacy of UC-MSCs in Patients With Plaque Psoriasis

Moderate and Severe Plaque Psoriasis

China
Tianjin Medical University Cancer Institute and...
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Not yet recruiting

A Study of Efbemalenograstim Alfa Injection for Stage IIIB or IV NSCLC Recieving Moderate-risk Febrile Neutropenia (FN) Chemotherapy Regimen With Risk Factors

Non Small Cell Lung Cancer

China
Hemay Pharmaceutical PTY. LTD.
Tianjin Hemay Pharmaceutical Co., Ltd

Unknown

PhaseⅠFirst-in-Human Study of Hemay007 in Healthy Volunteers

Inflammatory Bowel Disease

Australia
Tianjin Medical University Cancer Institute and...
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Not yet recruiting

Penpulimab-based Combination Neoadjuvant/Adjuvant Therapy for Patients With Resectable Locally Advanced Non-small Cell Lung Cancer: a Phase II Clinical Study (ALTER-L043) (ALTER-L043)

Resectable Locally Advanced Non-small Cell Lung Cancer

China
Tianjin Medical University Cancer Institute and...
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Not yet recruiting

Efficacy and Safety of Anlotinib, Irinotecan and Temozolomide in the Treatment of Refractory or Recurrent Neuroblastoma in Children: an Open, Single Arm, Single Center, Phase II Clinical Study

Refractory or Recurrent Neuroblastoma in Children
Tianjin Medical University Cancer Institute and...
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Completed

Study of Anlotinib Combined With Icotinib as the First-line Treatment in Patients With EGFR Mutation-positive NSCLC (ALTER-L004)

Non Small Cell Lung Cancer

China
Tianjin Medical University Cancer Institute and...
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Unknown

Study of Anlotinib Combined With Osimertinib as Second-line Treatment in Stage IIIb-IV NSCLC With Confirmed EGFRm and T790M (ALTN-03)

Non Small Cell Lung Cancer

China
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Tianjin Medical University Cancer Institute and Hospital

Unknown

To Predict Efficacy by Detecting Circulating Endothelial Cell Subsets and Blood Perfusion Parameters Changes in Vivo Tumor in the Phase II/III Study of Anlotinib in Patients With Advanced Non-small Cell Lung Cancer

Non-small Cell Lung Cancer

China
Arthro-Anda Tianjin Biologic Technology Co., Ltd.

Unknown

Study on Efficacy and Safety of CaReSR-1S to Repair Cartilage Defects of the Knee

Cartilage Defects

China
Tianjin Hemay Pharmaceutical Co., Ltd

Completed

Study Evaluating Hemay022 in Combination With Endocrine Therapy In Subjects With ER Positive and HER2 Positive Advanced Breast Cancer

Breast Cancer

China
Tianjin Hemay Pharmaceutical Co., Ltd

Terminated

Phase II Study of Hemay007 in Patients With Active Ulcerative Colitis

Ulcerative Colitis

China
Tianjin Hemay Pharmaceutical Co., Ltd

Completed

A Phase Ⅲ Efficacy and Safety Study of Hemay005 in Subjects With Moderate to Severe Plaque Psoriasis

Psoriasis

China
Tianjin Hemay Pharmaceutical Co., Ltd

Completed

A Phase I Clinical Study of Hemay808

Safety Issues

China
Tianjin Hemay Pharmaceutical Co., Ltd

Recruiting

A Phase Ⅲ Study of Hemay022 in Combination With AI In Advanced Breast Cancer

Breast Cancer

China
Tianjin Hemay Pharmaceutical Co., Ltd

Completed

Multiple Ascending Dose Study to Assess Safety and Pharmacokinetics of Hemay005 In Healthy Subjects (Hemay005)

Psoriasis

China
Tianjin Hemay Pharmaceutical Co., Ltd

Completed

A Phase Ⅱ Study of Hemay808 for Atopic Dermatitis Patients

Atopic Dermatitis

China
Tianjin Hemay Pharmaceutical Co., Ltd

Completed

Study Evaluating Hemay022 In Subjects With HER2-Positive Advanced Breast Cancer

HER2 Positive Breast Cancer

China
Tianjin Hemay Pharmaceutical Co., Ltd

Terminated

A Study to Evaluate the Efficacy and Safety of Hemay005 in the Treatment of Behçet Disease

Behçet Disease

China
Tianjin Hemay Pharmaceutical Co., Ltd

Completed

A Phase 2 Study of Hemay007 in Patients With Rheumatoid Arthritis

Rheumatoid Arthritis

China
Tianjin Hemay Pharmaceutical Co., Ltd

Completed

Phase II Study of Hemay005 in Patients With Active Ankylosing Spondylitis

Active Ankylosing Spondylitis

China
Tianjin Hemay Pharmaceutical Co., Ltd

Completed

Efficacy and Safety Study of Hemay005 in Subjects With Moderate to Severe Plaque Psoriasis

Psoriasis

China
Tianjin Chasesun Pharmaceutical Co., LTD
Southwest Hospital, China

Completed

Study of Multiple-dose Kukoamine B Mesilate in Healthy Volunteers

Healthy

China
Tianjin Chasesun Pharmaceutical Co., LTD
Southwest Hospital, China

Recruiting

Efficacy and Safety of Kukoamine B Mesilate in Sepsis Patients

Sepsis

China
Tianjin Demax Medical Technology Co., Ltd
CEISO

Not yet recruiting

GUIDEX® Versus Launcher™ Guiding Catheter in Percutaneous Coronary Intervention (PCI) (GUIDEX_FR) (GUIDEX®_FR)

Coronary Artery Disease

France

3

Subscribe